IPCA Laboratories Limited — Board Meeting, 17-10-2025: Outcome of Board Meeting
17-10-2025 | 05:29 pm
17-10-2025 | 05:29 pm
Ipca Labs Board approved selling its Ankleshwar API manufacturing unit for Rs 22.15 Cr to Suleshvari Pharma. This strategic move aims to optimize facilities and reduce costs, with no material impact on the company's business.
No comments yet. Be the first to comment!
